Cargando…
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients
(1) Background: Endocan is a marker of endothelial dysfunction that may be associated with thrombotic events. The aim of the study was to investigate the performance of endocan as a marker of thrombotic events in COVID-19 patients. (2) Methods: We measured endocan in plasma from 79 documented COVID-...
Autores principales: | Chenevier-Gobeaux, Camille, Ducastel, Morgane, Meritet, Jean-François, Ballaa, Yassine, Chapuis, Nicolas, Pene, Frédéric, Carlier, Nicolas, Roche, Nicolas, Szwebel, Tali-Anne, Terrier, Benjamin, Borderie, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572304/ https://www.ncbi.nlm.nih.gov/pubmed/36233427 http://dx.doi.org/10.3390/jcm11195560 |
Ejemplares similares
-
Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19
por: Ducastel, Morgane, et al.
Publicado: (2021) -
What applications for plasma endocan measurement in intensive care? A clarification
por: Dubar, Victoria, et al.
Publicado: (2023) -
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
por: Hadjadj, Jérôme, et al.
Publicado: (2020) -
Platelet activation in critically ill COVID-19 patients
por: Yatim, Nader, et al.
Publicado: (2021) -
Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments
por: Chenevier-Gobeaux, Camille, et al.
Publicado: (2019)